Clinical Studies

Information about the availability of clinical studies of VNS Therapy

Cyberonics is currently sponsoring a clinical study on VNS Therapy in patients with Treatment Resistant Depression. The objective of this study is to compare outcomes for patients with Treatment Resistant Depression who are receiving VNS Therapy at different doses. To learn more about this study, please click here: http://www.clinicaltrials.gov/ct/show/NCT00305565

Cyberonics is currently sponsoring the TRD Registry, the first registry specifically for patients with TRD. By collecting comprehensive data from > 2000 patients over 2 to 5 years, the TRD Registry will support rigorous analyses and substantially improve the understanding of TRD and available treatments. The primary objective of the TRD Registry is to follow the clinical course and outcome for patients with TRD treated with and without adjunctive VNS Therapy. To learn more about the TRD Registry, please go to the following website: http://www.clinicaltrials.gov/ct/show/NCT00320372 or to www.TRDRegistry.org to download an informational brochure.